Cyprus supports small markets' access to new expensive medicines, Hajipandela tells WHO Regional Committee
Cyprus supports small markets' access to new expensive medicines and the Oslo Medicines Initiative, Health Minister Michael Hadjipandela said on Monday, speaking at the 72nd session of the WHO Regional Committee for Europe, held in Tel Aviv.
Hajipandela pointed out that Cyprus is not considered an attractive market for the distribution of pharmaceutical companies' products. "This is particularly evident with new drugs at high prices, as Cyprus does not have the necessary numerical strength to allow them to be placed on the market, as well as the necessary negotiating power to secure fair pricing and compensation agreements," he added.
The Health Minister went on to say that Cyprus fully agrees with the creation of a multilateral platform such as the Oslo Medicines Initiative and intends to support this project.
In conclusion, Mr. Hajipandela said that the project should also include small markets' access to new high-priced medicines, adding that "this issue could be addressed separately, especially and in conjunction with the other priority areas."
Source: CNA
Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times
Source